Physician profile
Brittany Ackroyd
NPI 1174886485
$4,701.49
in general payments reported to CMS, 2019-2025
17 companies · $2,123 in 2025
The $2,123 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $75.65 · 2022: $400 · 2023: $772 · 2024: $1,331 · 2025: $2,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,225.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,125.01 | 2022-2025 | Aveir, Gallant, Jot Dx |
| Atricure, INC. | $1,045.66 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $427.20 | 2022-2025 | Lifevest |
| Medtronic, INC. | $426.31 | 2022-2025 | Pulseselect, Micra, Linq II |
| Biotronik INC. | $419.93 | 2024-2025 | Acticor 7 Vr-T Dx, Selectra, Solia |
| Boston Scientific Corporation | $311.37 | 2022-2025 | Watchman Flx |
| Impulse Dynamics (USA) INC. | $169.23 | 2023 | Optimizer |
| Janssen Pharmaceuticals, INC | $160.83 | 2022-2023 | Xarelto |
| Smith+Nephew, INC. | $146.66 | 2025 | Pico 14, Pico 7, Renasys Touch |
| Kestra Medical Technology Services, INC. | $125.71 | 2024-2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $78.47 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.81 | 2023-2025 | Jardiance |
| Cvrx, INC. | $51.12 | 2025 | Barostim Neo System |
| Novartis Pharmaceuticals Corporation | $44.67 | 2021 | |
| Abiomed | $42.47 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $40.00 | 2024 | Carto 3 |
| Pfizer INC. | $21.04 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Ackroyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.